Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

Event Details


Q3 2017 Charles River Laboratories International, Inc. Earnings Conference Call
Thursday, November 9, 2017 8:30 a.m. ET  
Webcast Presentation
Click here for webcast

Stock Quote

CRL (common)
Price
$104.88
Change (%)
- 1.12 (1.06%)
Volume
300,979
Exchange
NYSE
Data as of 12/14/17 4:02 p.m. ET
Data provided by Nasdaq.
Minimum 15 minutes delayed.

Refresh Quote

Investor Hotline

877-567-6CRL (6275)